The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lifelong disease burden of chemotherapy in Hodgkin lymphoma (HL): A simulation study from the St. Jude Lifetime (SJLIFE) Cohort and HL International Study for Individual Care (HoLISTIC).
 
Susan K. Parsons
No Relationships to Disclose
 
Nickhill Bhakta
No Relationships to Disclose
 
Angie Mae Rodday
No Relationships to Disclose
 
Carlton Scharman
No Relationships to Disclose
 
Marc André
No Relationships to Disclose
 
Massimo Federico
No Relationships to Disclose
 
Jonathan W. Friedberg
Consulting or Advisory Role - Astellas Pharma; Bayer; Portola Pharmaceuticals
Research Funding - Kite, a Gilead company (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)
Travel, Accommodations, Expenses - Roche
 
Debra L. Friedman
No Relationships to Disclose
 
Andrea Gallamini
Honoraria - Roche; Takeda
Speakers' Bureau - Takeda
Travel, Accommodations, Expenses - Takeda
 
Annette E. Hay
Research Funding - Amgen (Inst); Janssen (Inst); Novartis (Inst)
 
Brad S. Kahl
Consulting or Advisory Role - Abbvie; Acerta Pharma; ADC Therapeutics; AstraZeneca; Bayer; BeiGene; Celgene; Genentech; Janssen; Juno Therapeutics; Kite/Gilead; MEI Pharma; MorphoSys; Pharmacyclics; Pharmacyclics; Roche; TG Therapeutics
Research Funding - Acerta Pharma (Inst); ADC Therapeutics (Inst); Celgene (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Abbvie; Celgene; Genentech/Roche; Juno Therapeutics; Millennium; Seagen
 
Frank G. Keller
No Relationships to Disclose
 
Kara M. Kelly
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Ralph M. Meyer
No Relationships to Disclose
 
John Raemaekers
No Relationships to Disclose
 
Leslie L. Robison
No Relationships to Disclose
 
Melissa M. Hudson
Consulting or Advisory Role - Oncology Research Information Exchange Network; Princess Máxima Center; SurvivorLink
 
Joshua T. Cohen
Employment - Tufts Medical Center
Consulting or Advisory Role - Abbvie; Alnylam; Merck; Novartis; Precision Health Economics; Sage Therapeutics; Vertex
Research Funding - AdvaMed (Inst); Bluebird Bio (Inst); Genentech (Inst); Lundbeck (Inst)
 
Andrew M. Evens
Honoraria - Affimed Therapeutics; Bayer; Cota Healthcare; Epizyme; Miltenyi Biotec; MorphoSys; Novartis; Pharmacyclics; Research to Practice; Seagen; Verastem; Verastem
Consulting or Advisory Role - Affimed Therapeutics; Bayer; Cota Healthcare; Epizyme; Miltenyi Biotec; MorphoSys; Novartis; Pharmacyclics; Seagen; Verastem
Research Funding - Tesaro
Travel, Accommodations, Expenses - Affimed Therapeutics; Bayer; Novartis; Pharmacyclics; Research to Practice; Seagen; Verastem
 
F. Lennie Wong
No Relationships to Disclose